BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 26067887)

  • 1. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.
    Naik RD; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):969-82. PubMed ID: 26067887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-esophageal manifestations of gastroesophageal reflux.
    Farrokhi F; Vaezi MF
    Oral Dis; 2007 Jul; 13(4):349-59. PubMed ID: 17577320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-esophageal manifestations of GERD: who responds to GERD therapy?
    Naik RD; Vaezi MF
    Curr Gastroenterol Rep; 2013 Apr; 15(4):318. PubMed ID: 23435747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.
    Hom C; Vaezi MF
    Drugs; 2013 Aug; 73(12):1281-95. PubMed ID: 23881666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined?
    Moore JM; Vaezi MF
    Curr Opin Gastroenterol; 2010 Jul; 26(4):389-94. PubMed ID: 20473157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraesophageal presentations of GERD: where is the science?
    Madanick RD
    Gastroenterol Clin North Am; 2014 Mar; 43(1):105-20. PubMed ID: 24503362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentations of gastroesophageal reflux disease.
    Heidelbaugh JJ; Gill AS; Van Harrison R; Nostrant TT
    Am Fam Physician; 2008 Aug; 78(4):483-8. PubMed ID: 18756656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and initial management of gastroesophageal complications.
    Kamal A; Vaezi MF
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):799-820. PubMed ID: 21126695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-esophageal presentation of gastroesophageal reflux disease: new understanding in a new era.
    Martinucci I; Albano E; Marchi S; Blandizzi C
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):221-234. PubMed ID: 28260352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflux monitoring: on or off therapy?
    Vaezi MF
    Am J Gastroenterol; 2011 Feb; 106(2):183-5. PubMed ID: 21301447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antireflux surgery in the proton pump inhibitor era.
    Bulsiewicz WJ; Madanick RD
    Cleve Clin J Med; 2012 Apr; 79(4):273-81. PubMed ID: 22473727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraesophageal GERD.
    Frye JW; Vaezi MF
    Gastroenterol Clin North Am; 2008 Dec; 37(4):845-58, ix. PubMed ID: 19028321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.